These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26386566)

  • 1. Evaluation of the Safety and Effectiveness of Add-On Tacrolimus in Patients with Rheumatoid Arthritis Who Failed to Show an Adequate Response to Biological DMARDs: The Interim Results of a Specific Drug Use-Results Survey of Tacrolimus.
    Ishida K; Shiraki K; Yoshiyasu T
    Drugs R D; 2015 Dec; 15(4):307-17. PubMed ID: 26386566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effectiveness of tacrolimus add-on therapy for rheumatoid arthritis patients without an adequate response to biological disease-modifying anti-rheumatic drugs (DMARDs): Post-marketing surveillance in Japan.
    Takeuchi T; Ishida K; Shiraki K; Yoshiyasu T
    Mod Rheumatol; 2018 Jan; 28(1):48-57. PubMed ID: 28649878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midterm clinico-radiologic findings of an open label observation study of add-on tacrolimus with biologics or non-biologic DMARDs.
    Takakubo Y; Tamaki Y; Hirayama T; Iwazaki K; Yang S; Sasaki A; Nakano H; Konttinen YT; Takagi M
    Rheumatol Int; 2012 Nov; 32(11):3487-94. PubMed ID: 22065071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use.
    Takahashi N; Fujibayashi T; Kida D; Hirano Y; Kato T; Kato D; Saito K; Kaneko A; Yabe Y; Takagi H; Oguchi T; Miyake H; Watanabe T; Hayashi M; Kanayama Y; Funahashi K; Hanabayashi M; Hirabara S; Asai S; Takemoto T; Terabe K; Asai N; Yoshioka Y; Ishiguro N; Kojima T
    Rheumatol Int; 2015 Oct; 35(10):1707-16. PubMed ID: 25991396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effectiveness and safety of additional administration of tacrolimus in rheumatoid arthritis patients with an inadequate response to abatacept: A retrospective cohort study.
    Suzuki M; Takahashi N; Kida D; Hirano Y; Kato T; Yabe Y; Oguchi T; Fujibayashi T; Hayashi M; Asai S; Ishiguro N; Kojima T
    Int J Rheum Dis; 2019 Dec; 22(12):2199-2205. PubMed ID: 31647174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
    Yocum DE; Furst DE; Bensen WG; Burch FX; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisememandle W; Mekki QA;
    Rheumatology (Oxford); 2004 Aug; 43(8):992-9. PubMed ID: 15014199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of tacrolimus in infliximab-refractory progressive rheumatoid arthritis.
    Yokota K; Akiyama Y; Asanuma Y; Miyoshi F; Sato K; Mimura T
    Rheumatol Int; 2009 Feb; 29(4):459-61. PubMed ID: 18802706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of adjunct tacrolimus treatment in patients with rheumatoid arthritis with inadequate responses to methotrexate.
    Kitahama M; Nakajima A; Inoue E; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2013 Jul; 23(4):788-93. PubMed ID: 22975732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
    Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
    Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-marketing surveillance of the safety and effectiveness of tacrolimus in 3,267 Japanese patients with rheumatoid arthritis.
    Takeuchi T; Kawai S; Yamamoto K; Harigai M; Ishida K; Miyasaka N
    Mod Rheumatol; 2014 Jan; 24(1):8-16. PubMed ID: 24261753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK506) in the treatment of severe, refractory rheumatoid arthritis: initial experience in 12 patients.
    Gremillion RB; Posever JO; Manek N; West JP; van Volen-Hoven RF
    J Rheumatol; 1999 Nov; 26(11):2332-6. PubMed ID: 10555886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating cell free DNA: a marker to predict the therapeutic response for biological DMARDs in rheumatoid arthritis.
    Hashimoto T; Yoshida K; Hashimoto N; Nakai A; Kaneshiro K; Suzuki K; Kawasaki Y; Shibanuma N; Hashiramoto A
    Int J Rheum Dis; 2017 Jun; 20(6):722-730. PubMed ID: 27943573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of additional use of tacrolimus in patients with early rheumatoid arthritis with inadequate response to DMARDs--a multicenter, double-blind, parallel-group trial.
    Kawai S; Takeuchi T; Yamamoto K; Tanaka Y; Miyasaka N
    Mod Rheumatol; 2011 Oct; 21(5):458-68. PubMed ID: 21347803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-center, retrospective analysis of efficacy and safety of tacrolimus as a second-line DMARD in combination therapy and the risk factors contributing to adverse events in 115 patients with rheumatoid arthritis.
    Ogasawara M; Tamura N; Kageyama M; Onuma S; Kusaoi M; Toyama S; Sekiya F; Matsudaira R; Nawata M; Tada K; Matsushita M; Kempe K; Amano H; Morimoto S; Yamaji K; Takasaki Y
    Clin Rheumatol; 2012 Feb; 31(2):251-7. PubMed ID: 21773713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus: in patients with rheumatoid arthritis.
    Curran MP; Perry CM
    Drugs; 2005; 65(7):993-1001; discussion 1002-3. PubMed ID: 15892590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis.
    Kitahama M; Okamoto H; Koseki Y; Inoue E; Kaneko H; Taniguchi A; Momohara S; Yamanaka H
    Mod Rheumatol; 2010 Oct; 20(5):478-85. PubMed ID: 20552247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [DMARDs (disease-modifying antirheumatic drugs)].
    Tanaka E; Yamanaka H
    Nihon Rinsho; 2013 Jul; 71(7):1199-206. PubMed ID: 23961667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug survival and the associated predictors in South Korean patients with rheumatoid arthritis receiving tacrolimus.
    Park EY; Lee SG; Park EK; Koo DW; Park JH; Kim GT; Tag HS; Kim HO; Suh YS
    Korean J Intern Med; 2018 Jan; 33(1):193-202. PubMed ID: 27048254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of joint destruction by tacrolimus in patients with early rheumatoid arthritis: a post hoc analysis of a double-blind, randomized, placebo-controlled study.
    Tanaka Y; Kawai S; Takeuchi T; Yamamoto K; Miyasaka N
    Mod Rheumatol; 2013 Nov; 23(6):1045-52. PubMed ID: 23271170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of once-daily modified-release tacrolimus in kidney transplant recipients: interim analysis of multicenter postmarketing surveillance in Japan.
    Takahashi K; Abe R; Usuki S; So M
    Transplant Proc; 2014; 46(2):406-10. PubMed ID: 24655975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.